From standard to individualized diazoxide therapy in congenital hyperinsulinism: a narrative review

Frontiers in Pharmacology 2026 Open access

Read full text
Authors: Teresa Wong, Daniel Chan, Cherie Chua, Wenqi Cher, Selina Lim, Suresh Chandran, Fabian K. P. Yap
DOI: 10.3389/fphar.2026.1781424
Cited by: 1
References: 90

Abstract

Purpose Congenital hyperinsulinism (CHI) is the commonest cause of persistent hypoglycaemia in neonates and infants (blood glucose

Fields of Study & Subjects

Hyperglycemia and glycemic control in critically ill and hospitalized patients Diabetes Management and Research Neonatal Respiratory Health Research

Publication details

Journal / source
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Volume
17
Pages
1781424–1781424
Publication date
30 March 2026
Language
EN